These findings indicate that CypD inhibition stabilizes mitochondrial membrane potential, thereby attenuating T. cruzi pathogenicity and dissemination [90], highlighting CypD as a promising therapeutic target to mitigate cardiac damage in Chagas disease. Here, PPID is linked to Chagas disease.